A key area of research is the discovery of new antibiotics produced by environmental microbes. To succeed in this, we operate at the forefront of science using high-throughput sequencing technologies for full-genome sequencing, genome-resolved metagenomics, single cell genomics, and amplicon sequencing. Furthermore, we utilize state-of-the-art visualization and labelling techniques to analyze natural microbial communities and their potential to produce novel antibiotics.
In addition to harnessing the biosynthesis potential of microorganism in the pursuit for novel antibiotics, we also aim at understanding the role of specialized metabolites and their producers in the shaping of microbiome composition and function. With this information, we can engineer and enhance microbiomes in a predictable and controllable manner e.g. in order to reduce the need for antibiotics in aquaculture.